This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by La Posta, V J Articles by Cole, G A Search for Related Content PubMed PubMed Citation Articles by La Posta, V J Articles by Cole, G A

 Previous Article  |  Next Article 

J Virol. 1993 June; 67(6): 3497-3506

Cross-protection against lymphocytic choriomeningitis virus mediated by a CD4+ T-cell clone specific for an envelope glycoprotein epitope of Lassa virus.

Department of Microbiology and Immunology, University of Maryland, Baltimore 21201.

ABSTRACT

Recombinant vaccinia virus expressing the Lassa virus (LV) envelope glycoprotein precursor, V-LSGPC, was used to study the basis of LV-induced cross-protective immunity against the closely related arenavirus lymphocytic choriomeningitis virus (LCMV). C3H/HeJ mice primed with V-LSGPC developed neither circulating antibodies nor CD8+ cytotoxic T cells specific for LCMV, yet they resisted a normally lethal LCMV challenge. Spleen cells from such mice gave a proliferative response to LCMV in vitro that was inhibitable by anti-CD4 antibody. Synthetic peptides corresponding to predicted T-cell sites common to the envelope glycoprotein precursor (GP-C) of LV and that of LCMV were used to map the specificity of the proliferative response to an epitope located between amino acids 403 and 417 of LV GP-C. Several CD4+ T-cell clones specific for the 403-417 peptide were isolated and found to produce gamma interferon in response to both the peptide and LCMV. One of these clones, C9, was selected for further study. C9 lysed I-AK-bearing target cells, and when adoptively transferred to C3H/HeJ mice, it was capable of mediating both a peptide-specific delayed hypersensitivity reaction and resistance to lethal LCMV challenge. These collective findings demonstrate, for the first time, that CD4+ T cells can play a major role in arenavirus-specific cross-protective immunity.

This article has been cited by other articles:

• Pushko, P., Geisbert, J., Parker, M., Jahrling, P., Smith, J. (2001). Individual and Bivalent Vaccines Based on Alphavirus Replicons Protect Guinea Pigs against Infection with Lassa and Ebola Viruses. J. Virol. 75: 11677-11685 [Abstract] [Full Text]  
• Bowen, M. D., Rollin, P. E., Ksiazek, T. G., Hustad, H. L., Bausch, D. G., Demby, A. H., Bajani, M. D., Peters, C. J., Nichol, S. T. (2000). Genetic Diversity among Lassa Virus Strains. J. Virol. 74: 6992-7004 [Abstract] [Full Text]  
• ter Meulen, J., Badusche, M., Kuhnt, K., Doetze, A., Satoguina, J., Marti, T., Loeliger, C., Koulemou, K., Koivogui, L., Schmitz, H., Fleischer, B., Hoerauf, A. (2000). Characterization of Human CD4+ T-Cell Clones Recognizing Conserved and Variable Epitopes of the Lassa Virus Nucleoprotein. J. Virol. 74: 2186-2192 [Abstract] [Full Text]